MM
Agree totally. I have accumulated 15% of this company for clients/personal and will continue to buy anything around these prices. Next Friday I am in Queenstown and will be catching up with Richard Hopkins and other experts and seeing just where the potential lies here.
Epichem is going great guns, and we now have Hopkins/Mollard putting thing together nicely. MPL already showing some promising signs in canines, but the real cheesecake will be the human trials.
Very tightly held, still lacking a profile and stupid cheap. Not even the value of Epichem is factored in to the market capitalisation. I am expecting big things and a chance that the unlisted 12c options will one day find themselves deep in the money.
Possible breakout, page-84
Add NUZ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $93.42M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 19.3¢ | 19.0¢ | $25.41K | 133.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5372 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 262575 | 3 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| NUZ (ASX) Chart |